Cite
HARVARD Citation
Alghazali, M. et al. (2019). A registry-based study evaluating overall survival and treatment duration in Swedish patients with metastatic castration-resistant prostate cancer treated with enzalutamide. Scandinavian journal of urology. pp. 312-318. [Online].